Relations of Change in Plasma Levels of LDL‐C, Non‐HDL‐C and apoB With Risk Reduction From Statin Therapy: A Meta‐Analysis of Randomized Trials

BACKGROUND: Identifying the best markers to judge the adequacy of lipid‐lowering treatment is increasingly important for coronary heart disease (CHD) prevention given that several novel, potent lipid‐lowering therapies are in development. Reductions in LDL‐C, non‐HDL‐C, or apoB can all be used but w...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanassoulis, George, Williams, Ken, Ye, Keying, Brook, Robert, Couture, Patrick, Lawler, Patrick R., de Graaf, Jacqueline, Furberg, Curt D., Sniderman, Allan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187506/
https://www.ncbi.nlm.nih.gov/pubmed/24732920
http://dx.doi.org/10.1161/JAHA.113.000759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187506/
https://www.ncbi.nlm.nih.gov/pubmed/24732920
http://dx.doi.org/10.1161/JAHA.113.000759

Ejemplares similares